Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

Genes to Cells

Volumn 4, Issue 6, 1999, Pages 353-362

  Naito, Asuka ^a   Azuma, Sakura ^a   Tanaka, Sakae ^b   Miyazaki, Tsuyoshi ^b   Takaki, Satoshi ^a   Takatsu, Kiyoshi ^a   Nakao, Kazuki ^a   Nakamura, Kenji ^a   Katsuki, Motoya ^a   Yamamoto, Tadashi ^a   Inoue, Jun Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALBERS SCHOENBERG DISEASE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; IN VITRO STUDY; LYMPH NODE; MOUSE; NONHUMAN; ORGANOGENESIS; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; EMBRYONIC AND FETAL DEVELOPMENT; INTERLEUKIN-1; LYMPH NODES; MICE; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPETROSIS; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SPLEEN; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 6544270833     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.1999.00265.x     Document Type: Article

References (43)

1. Adachi, O., Kawai, T., Takeda, K., et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL- 18-mediated function. Immunity 9, 143-150.
2. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
3. Arch., R.H., Gedrich, R.W. & Thompson, C.B. (1998) Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 12, 2821-2830.
4. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D.V. (1996) TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446.
5. Cheng, G., Cleary, A.M., Ye, Z.S., Hong, D.I., Lederman, S. & Baltimore, D. (1995) Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498.
6. Darnay, B.G., Haridas, V., Ni, J., Moore, P.A. & Aggarwal, B.B. (1998) Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J. Biol. Chem. 273, 20551-20555.
7. Franzoso, G., Carlson, L., Xing, L., et al. (1997) Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11, 3482-3496.
8. Galibert, L., Tometsko, M.E., Anderson, D.M., Cosman, D. & Dougall, W.C. (1998) The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily. J. Biol. Chem. 273, 34120-34127.
9. Godfrey, D.I., Kennedy, J., Suda, T. & Zlotnik, A. (1993) A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol 150, 4244-4252.
10. Grigoriadis, A.E., Wang, Z.Q., Cecchini, M.G., et al. (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448.
11. Hu, H.M., O'Rourke, K., Boguski, M.S. & Dixit, V.M. (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072.
12. Iotsova, V., Caamano, J., Loy, J., Yang, Y., Lewin, A. & Bravo, R. (1997) Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nature Med. 3, 1285-1289.
13. Ishida, T., Mizushima, S., Azuma, S., et al. (1996a) Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745-28748.
14. Ishida, T.K., Tojo, T., Aoki, T., et al. (1996b) TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93, 9437-9442.
15. Kawabe, T., Naka, T., Yoshida, K., et al. (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
16. Kong, Y.Y., Yoshida, H., Sarosi, I., et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
17. Labow, M., Shuster, D., Zetterstrom, M., et al. (1997) Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159, 2452-2461.
18. Lacey, D.L., Timms, E., Tan, H.L., et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
19. Lomago, M.A., Yeh, W.-C., Sarosi, I., et al. (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024.
20. Minkin, C. (1982) Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34, 285-290.
21. Miyamoto, S. & Verma, I.M. (1995) Rel/NF-κB/IκB story. Adv. Cancer Res. 66, 255-292.
22. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. & Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
23. Muzio, M., Natoli, G., Saccani, S., Levrero, M. & Mantovani, A. (1998) The human toll signaling pathway: divergence of nuclear factor KB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187, 2097-2101.
24. Nakano, H., Oshima, H., Chung, W., et al. (1996) TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271, 14661-14664.
25. Ninomiya, T.J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z. & Matsumoto, K. (1999) The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature 398, 252-256.
26. Nishitoh, H., Saitoh, M., Mochida, Y., et al. (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2, 389-395.
27. Okada, S., Wang, Z.-Q., Grigodiadis, A.E., Wagner, E.F. & von Rüden, T. (1994) Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol. Cell. Biol. 14, 382-390.
28. Popoff, S.N. & Marks, S.C. Jr (1995) The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development. Bone 17, 437-445.
29. Regnier, C.H., Tomasetto, C., Moog-Lutz, C., et al. (1995) Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715-25721.
30. Rothe, M., Sarma, V., Dixit, V.M. & Goeddel, D.V. (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424-1427.
31. Rothe, M., Wong, S.C., Henzel, W.J. & Goeddel, D.V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
32. Sato, T., Irie, S. & Reed, J.C. (1995) A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358, 113-118.
33. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702.
34. Takano-Yamamoto, T. & Rodan, G.A. (1990) Direct effects of 17β-estradiol on trabecular bone in ovariectomized rats. Proc. Natl. Acad. Sci. USA 87, 2172-2176.
35. Tondravi, M.M., McKercher, S.R., Anderson, K., et al. (1997) Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81-84.
36. Tsukamoto, N., Kobayashi, N., Azuma, S., Yamamoto, T. & Inoue, J. (1999) Two differently regulated nuclear factor KB activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA 96, 1234-1239.
37. Wiktor-Jedrzejckaz, W., Ahmed, A., Szczylik, C. & Skelly, R.R. (1982) Hematological characterization of congenital osteopetrosis in op/op mouse: Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156, 1516-1527.
38. Wong, B.R., Josien, R., Lee, S.Y., et al. (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080.
39. Wong, B.R., Josien, R., Lee, S.Y., Vologodskaia, M., Steinman, R.M. & Choi, Y. (1998) The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J. Biol Chem. 273, 28355-28359.
40. Xu, Y., Cheng, G. & Baltimore, D. (1996) Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5, 407-415.
41. Yasuda, H., Shima, N., Nakagawa, N., et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597-3602.
42. Yeh, W.C., Shahinian, A., Speiser, D., et al. (1997) Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
43. Yoshida, H., Hayashi, S., Kunisada, T., et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442-444.